CHICAGO (February 2, 2026) – With over 31 million people currently using GLP-1 drugs like Ozempic and Mounjaro, the conversation has shifted from weight loss success stories to serious legal questions. As of early 2026, over 3,000 lawsuits are pending against the manufacturers of GLP-1 drugs. The lawsuits claim plaintiffs who used the drugs suffered severe side effects such as stomach paralysis, bowel obstructions, and vision loss, along with failure-to-warn and misleading marketing.
FOX 32 anchor Anita Blanton recently sat down with Salvi, Schostok & Pritchard attorney Matthew L. Williams to break down the rising wave of product liability lawsuits facing pharmaceutical manufacturers.
